Follow
Ovarian Cancer
Ovarian Cancer: is a cancer that ignites in the female organs that produce eggs (ovaries). Ovarian cancer frequently goes undetected until it has spread within the pelvis and belly. At this late stage, ovarian cancer is more severe to treat and can be fatal.
What's Popular in Ovarian Cancer
-
SEP 07, 2023Cancer
Obesity, characterized as an abnormally high, unhealthy amount of body fat, has become a common disease throughout the U ...Written By: Katie KokolusSEP 04, 2023Cancer
Today, we commemorate Labor Day, a holiday recognizing the American workforce's contributions toward the United Stat ...Written By: Katie KokolusMAY 10, 2023Cancer
Yesterday the U.S. Preventative Service Task Force (USPSTF) announced an updated recommendation for breast cancer screen ...Written By: Katie KokolusFEB 27, 2023Cell & Molecular Biology
The genome of a cell carries all the genes it will ever need, and when a gene is active, it gets transcribed into messen ...Written By: Carmen LeitchFEB 16, 2023Clinical & Molecular DX
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a powerful tool for identifying the compounds in a sample; ...Written By: Carmen Leitch
SEP 07, 2023
Cancer
Obesity, characterized as an abnormally high, unhealthy amount of body fat, has become a common disease throughout the U
...
Written By:
Katie Kokolus
SEP 04, 2023
Cancer
Today, we commemorate Labor Day, a holiday recognizing the American workforce's contributions toward the United Stat
...
Written By:
Katie Kokolus
MAY 10, 2023
Cancer
Yesterday the U.S. Preventative Service Task Force (USPSTF) announced an updated recommendation for breast cancer screen
...
Written By:
Katie Kokolus
FEB 27, 2023
Cell & Molecular Biology
The genome of a cell carries all the genes it will ever need, and when a gene is active, it gets transcribed into messen
...
Written By:
Carmen Leitch
FEB 16, 2023
Clinical & Molecular DX
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) is a powerful tool for identifying the compounds in a sample;
...
Written By:
Carmen Leitch
JAN 25, 2023
Cancer
Breast cancer remains the most common cancer in women in the United States. Experts estimated 287,850 breast cance
...
Written By:
Katie Kokolus
JAN 19, 2023
Cancer
Epidemiological evidence has established that race and ethnicity play a role in the incidence of several types of cancer
...
Written By:
Katie Kokolus
DEC 08, 2022
Cancer
Chemotherapies, drugs used to fight cancer by killing tumor cells or preventing them from growing and dividing, remain s
...
Written By:
Katie Kokolus
NOV 29, 2022
Drug Discovery & Development
A common chemotherapy drug may make future generations more susceptible to disease. The corresponding study was publishe
...
Written By:
Annie Lennon
-
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...OCT 10, 2023 | 10:00 AMC.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...SEP 20, 2022 | 9:00 AM
Date: September 20, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Variation in gene expression among cell types, tissues, and organisms is commonly examined by reverse transcription...MAY 24, 2022 | 11:00 AM
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...Speaker: Dr. Christopher Lum, M.D. , Zan Halford, M.S. SMB(ASCP)CM,Sponsored By: BioDiscovery, A Bionano Genomics Company
OCT 10, 2023 | 1:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 9:00 AM
Numerous studies have shown that homologous recombination deficiency (HRD) is a genome-wide biomarker present in high grade ovarian and breast cancers. A cancer therapeutic class, PARP inhib...
OCT 10, 2023 | 10:00 AM
C.E. CREDITS
For patients with advanced non-small cell lung cancer (NSCLC), tissue samples are typically small biopsies. These samples undergo standard of care evaluation for >10 biomarkers to identif...
SEP 20, 2022 | 9:00 AM
Date: September 20, 2022 Time: 9:00am (PDT), 12:00pm (EDT), 6:00pm (CEST) Variation in gene expression among cell types, tissues, and organisms is commonly examined by reverse transcription...
MAY 24, 2022 | 11:00 AM
Date: May 24, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 7:00pm (CEST) NGS tumor profiling has become the mainstay of modern cancer therapy. Several NCCN-guided and FDA-approved therapies are c...
Speaker:
Dr. Christopher Lum, M.D.
, Zan Halford, M.S. SMB(ASCP)CM,
Sponsored By: BioDiscovery, A Bionano Genomics Company
MAR 31, 2022 | 11:00 AM
Date: March 31, 2022 Time: 11:00am (PDT), 2:00pm (EDT), 8:00pm (CET) Formalin-fixed paraffin-embedded (FFPE) tissues are the most widely used clinical sample types in histology and molecular...
JUN 08, 2021 | 10:00 AM
Date: June 8, 2021 Time: 10:00am (PDT), 1:00pm (EDT) Most deaths from ovarian and endometrial cancer are due to high-grade subtypes that metastasize before they are detectable by available...
NOV 20, 2020 | 9:30 AM
...
OCT 21, 2020 | 9:25 PM
High grade serous ovarian cancer is characterized by genomic instability, with ~50% of advanced tumors harboring homologous recombination repair (HRR) pathway deficiency (HRD). HRD results i...
Speaker:
Natalie Ngoi, MBBS, MMed, MRCP
Presented at: OncomineWorld 2022: A Virtual NGS Education Meeting
-
DEC 07, 2021 | 12:00 PM PST
Date: December 7, 2021 Time: 12:30-5:00 p.m. ET #NCATS10...SEP 08, 2021 | 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...APR 10, 2019 | 6:00 AM PDT
The 4th Annual Event in the Molecular Diagnostics Virtual Event Series is now available On Demand!...
DEC 07, 2021
| 12:00 PM PST
Date: December 7, 2021 Time: 12:30-5:00 p.m. ET #NCATS10...
SEP 08, 2021
| 6:00 AM PDT
Luminex's xMAP® Technology enables the evaluation of up to 500 analytes simultaneously in a single well, known as multiplexing. xMAP Technology uses color-coded microspheres as the substrate...
10/14-15 9am-1pm CDT
Coming to you from a safe, physical distance, 2020 Abbott World Summit. This event will feature over 15 global experts sharing their latest discoveries and experiences in cancer screening, r...
10/13-14 from 1-5pm SGT
Coming to you from a safe, physical distance, Abbott 2020 world oncology summit. Covering diverse and timely topics in cancer education, from updates in cancer emerging new diagnostics resea...
APR 10, 2019
| 6:00 AM PDT
The 4th Annual Event in the Molecular Diagnostics Virtual Event Series is now available On Demand!...
OCT 10, 2018
| 6:00 AM PDT
The 6th Annual Event in the Cancer Research & Oncology Week Virtual Event Series will take place October 2018....
MAY 09, 2018
| 6:00 AM PDT
C.E. CREDITS
LabRoots is excited to announce the 6th Annual Event in the Genetics and Genomics Virtual Event Series!...
FEB 21, 2018
| 6:00 AM PST
Labroots and the Drug Discovery planning committee are pleased to announce its 1st annual event in the Drug Discovery Virtual Event Series!...
OCT 11, 2017
| 6:00 AM PDT
The 5th Annual Event in the Cancer Research & Oncology Week Virtual Event Series is now On-Demand!...